You just read:

Biostage awarded SBIR Fast-Track grant to develop Cellspan™ Esophageal Implant (CEI) as a novel treatment for esophageal atresia in pediatric patients

News provided by

Biostage, Inc.

Mar 29, 2018, 08:00 ET